← Back to Search

Behavioural Intervention

rTMS for Anorexia Nervosa

N/A
Waitlist Available
Led By Alexandra F Muratore, PhD
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to post-treatment (approx. 1 week apart)
Awards & highlights

Study Summary

This trial will find out how magnetic stimulation affects eating habits and the brain's response.

Who is the study for?
This trial is for right-handed women aged 18-30 with a diagnosis of Anorexia Nervosa according to DSM-5, having a BMI of at least 16.0. Participants must be voluntarily admitted to an inpatient eating disorders unit, medically stable, competent to consent, and English-speaking.Check my eligibility
What is being tested?
The study tests the effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on food choice behavior compared to sham rTMS which mimics the procedure without active treatment.See study design
What are the potential side effects?
Possible side effects from rTMS may include discomfort at the stimulation site, headache, lightheadedness or seizures; however, these are generally rare and the procedure is considered safe.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to post-treatment (approx. 1 week apart)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to post-treatment (approx. 1 week apart) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neural activity and functional connectivity during the food choice task
Restrictive eating behavior during the food choice task
Secondary outcome measures
Predictors of HF-rTMS response

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS)Experimental Treatment1 Intervention
Target: Region of right DLPFC with greatest resting-state functional connectivity to dorsal striatum (individualized functional target) Protocol: 10 pulses/sec, 4s trains, 120% MT, 3000 pulses/session
Group II: Sham repetitive transcranial magnetic stimulation (sham rTMS)Placebo Group1 Intervention
Target: Region of right DLPFC with greatest resting-state functional connectivity to dorsal striatum (individualized functional target) Protocol: same as HF-rTMS, with sham coil

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,783 Previous Clinical Trials
2,689,055 Total Patients Enrolled
47 Trials studying Anorexia Nervosa
22,771 Patients Enrolled for Anorexia Nervosa
New York State Psychiatric InstituteLead Sponsor
475 Previous Clinical Trials
153,835 Total Patients Enrolled
19 Trials studying Anorexia Nervosa
1,060 Patients Enrolled for Anorexia Nervosa
Global Foundation for Eating DisordersUNKNOWN
1 Previous Clinical Trials
11 Total Patients Enrolled

Media Library

High-frequency repetitive transcranial magnetic stimulation (active rTMS) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05918835 — N/A
Anorexia Nervosa Research Study Groups: Sham repetitive transcranial magnetic stimulation (sham rTMS), High-frequency repetitive transcranial magnetic stimulation (HF-rTMS)
Anorexia Nervosa Clinical Trial 2023: High-frequency repetitive transcranial magnetic stimulation (active rTMS) Highlights & Side Effects. Trial Name: NCT05918835 — N/A
High-frequency repetitive transcranial magnetic stimulation (active rTMS) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05918835 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I be accepted as a participant in this clinical experiment?

"Those with anorexia nervosa who are aged between 18 and 30 may qualify for this clinical trial, of which a maximum of 72 people can be enrolled."

Answered by AI

Is the enrollment process currently open to individuals aged 35 and up?

"Enrolment into this medical trial is limited to those aged 18 years or older, and no more than 30."

Answered by AI

Are physicians now enrolling participants for this experiment?

"As per the information hosted on clinicaltrials.gov, this study is not currently enrolling participants as of June 16th 2023. The trial had been posted four months prior, but halted recruitment for unknown reasons. Although there are 84 other trials actively recruiting at present."

Answered by AI
~48 spots leftby Jun 2027